Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.57 |
| ▸ | CES1 | P23141 | 4/20 | 0.57 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.55 |
| ▸ | PPARG | P37231 | 7/20 | 0.55 |
| ▸ | PPARD | Q03181 | 7/20 | 0.55 |
| ▸ | PPARA | Q07869 | 7/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.55 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | PDE4A | P27815 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368594 | 1.00 | — | — | |
| SCHEMBL3652374 | 1.00 | CES2 (0.57) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL4814086 | 1.00 | CES2 (0.57) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL23892 | 1.00 | CES2 (0.57) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL181532 | 1.00 | CES2 (0.57) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL7524933 | 1.00 | CES2 (0.57) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL4649868 | 1.00 | CES2 (0.57) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL1815133 | 1.00 | CES2 (0.57) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL1604061 | 1.00 | CES2 (0.57) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL7743611 | 1.00 | CES2 (0.57) | CES2CES1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 627 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115864-A1 | A FERMENTATION MEDIUM COMPRISING SULPHUR | EVONIK OPERATIONS GMBH (DE) | 2025-04-10 | — | — | US | claimed |
| US-12227522-B2 | Synthesis of structural analogs of largazole and associated compounds | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2025-02-18 | — | — | US | claimed |
| CN-119463312-A | Rubber material for supporting transmission shaft and preparation method thereof | 芜湖佳先传动轴有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119213131-A | Compositions and methods for transforming embryo explant populations | 孟山都技术公司 | 2024-12-27 | — | — | CN | claimed |
| EP-4409012-A1 | A FERMENTATION MEDIUM COMPRISING SULPHUR | Evonik Operations GmbH (DE) | 2024-08-07 | — | — | EP | claimed |
| CN-118344731-A | Reworkable poly lipoic acid ion gel and application of anti-fouling paint thereof | 南京理工大学 | 2024-07-16 | — | — | CN | claimed |
| CN-118271615-A | Sulfur-containing polymer-based optical material with high light transmittance, high refraction and low dispersion and preparation method thereof | 常州汉韦聚合物有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118272038-A | Adhesive, preparation method thereof and adhesive application method | 衢州化工新材料创新研究院 | 2024-07-02 | — | — | CN | claimed |
| CN-117929575-A | Method for detecting oxidized impurities in lipoic acid soft capsules | 姜洲煜 | 2024-04-26 | — | — | CN | claimed |
| CN-117703936-A | Bearing with enhanced sealing solid oil lubricity, water resistance and sundry resistance and manufacturing method | 上海龙禾帆科技有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-101426800-A | Rubber composition containing organofunctional silane | MOMENTIVE PERFORMANCE MAT INC (US) | 2009-05-06 | — | — | CN | claimed |
| EP-1594835-A4 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS INC (US) | 2007-05-02 | — | — | EP | claimed |
| US-20060173199-A1 | Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses | HONG BORCHERNG | 2006-08-03 | — | — | US | claimed |
| US-20060115880-A1 | Enzymatic production of acyl flavonoid derivatives | COGNIS FRANCE S.A. (FR) | 2006-06-01 | — | — | US | claimed |
| EP-1594835-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | Auspex Pharmaceuticals, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2004064745-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS, INC. (US) | 2004-08-05 | — | — | WO | claimed |
| EP-0753341-B1 | Use of hydrofluorocarbon thiolesters in emulsions, cosmetic or dermatalogical applications | OREAL (FR) | 1997-07-23 | — | — | EP | claimed |
| EP-0753341-A1 | Use of hydrofluorocarbon thiolesters in emulsions, cosmetic or dermatalogical applications | L'OREAL (FR) | 1997-01-15 | — | — | EP | claimed |
| EP-0078562-B1 | ACARICIDAL COMPOSITIONS | SOCIETE D'ETUDES ET DE REALISATIONS SCIENTIFIQUES, en abrégé S.E.R.E.S.C.I., S.P.R.L. (BE) | 1986-01-29 | — | — | EP | claimed |
| EP-0078562-A1 | Acaricidal compositions | SOCIETE D'ETUDES ET DE REALISATIONS SCIENTIFIQUES, en abrégé S.E.R.E.S.C.I., S.P.R.L. (BE) | 1983-05-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12227522-B2 | Synthesis of structural analogs of largazole and associated compounds | AADAC, MTTP, CYP51A1 | CES2 333/4885CES1 59/4885GPR84 1467/4885 |
| US-20060173199-A1 | Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses | LSS, DHPS, CYP51A1 | CES2 2017/4885CES1 1016/4885GPR84 4657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.